Monday, July 08, 2024 9:54:13 PM
Will look into it... I noticed that promotion of cystine was one of it's positive effects.
Early in the COVID "crisis" I had some serious pulmonary issues. I went to the hospital but I signed out of the hospital AMA because I thought their treatment was inappropriate. I've been taking NAC for a long time and I feel it was critical in my recovery from the first FQ poisoning
I went home and had to sleep upright in an armchair, couldn't lay down. I knew I was dying. About two hours after my regular morning dose I noticed my pulse ox readings improved. So I started googling, noted the half life stats (5.6 hours) and also researched overdose levels - I couldn't find any dangerous levels. So instead of the 600 mg 3x per day that I'd been taking for a decade or so I switched to 1200mg every 2-3 hours.
I didn't die...
I had an adequate supply because my family bought a case of it from a willing wholesaler and had it shipped in.
How many lives could have been saved with NAC?
Here's how I discovered NAC - I was reading a health food store ad somewhere around year 2000... I knew I was in trouble, so I was praying while I was reading. In the upper right hand corner of the ad "NAC" was advertised. I kept going back to it because I had no idea what it was. I did my research and started taking it at the recommended 600mg 3x per day recommended. In time I got better, back to my "normal" self and even improved lung function. . I had bad lungs to begin with because I inhaled HCL acid in H.S. chem class. Then I got Valley Fever when I was in Tucson for a trade show. I was given Cipro for a fungal infection and I got worse. I tried every asthma drug that came along, with limited success and actually reversed most of the damage with NAC until COVID came along.
As stated earlier today, I now suspect that the gadolinium administered during hospitalization caused as much or more damage than COVID.
Early in the COVID "crisis" I had some serious pulmonary issues. I went to the hospital but I signed out of the hospital AMA because I thought their treatment was inappropriate. I've been taking NAC for a long time and I feel it was critical in my recovery from the first FQ poisoning
I went home and had to sleep upright in an armchair, couldn't lay down. I knew I was dying. About two hours after my regular morning dose I noticed my pulse ox readings improved. So I started googling, noted the half life stats (5.6 hours) and also researched overdose levels - I couldn't find any dangerous levels. So instead of the 600 mg 3x per day that I'd been taking for a decade or so I switched to 1200mg every 2-3 hours.
I didn't die...
I had an adequate supply because my family bought a case of it from a willing wholesaler and had it shipped in.
How many lives could have been saved with NAC?
Here's how I discovered NAC - I was reading a health food store ad somewhere around year 2000... I knew I was in trouble, so I was praying while I was reading. In the upper right hand corner of the ad "NAC" was advertised. I kept going back to it because I had no idea what it was. I did my research and started taking it at the recommended 600mg 3x per day recommended. In time I got better, back to my "normal" self and even improved lung function. . I had bad lungs to begin with because I inhaled HCL acid in H.S. chem class. Then I got Valley Fever when I was in Tucson for a trade show. I was given Cipro for a fungal infection and I got worse. I tried every asthma drug that came along, with limited success and actually reversed most of the damage with NAC until COVID came along.
As stated earlier today, I now suspect that the gadolinium administered during hospitalization caused as much or more damage than COVID.
Recent AVXL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
- Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 • GlobeNewswire Inc. • 02/03/2026 12:30:00 PM
- Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease • GlobeNewswire Inc. • 01/13/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:26:26 PM
- Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm • PR Newswire (US) • 01/09/2026 01:13:00 AM
- Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/06/2026 12:30:00 PM
- Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion • GlobeNewswire Inc. • 12/18/2025 12:30:00 PM

